Placeholder Banner

Buzz at BIO: Dr. Julie Gerberding, Merck

Andrew Segerman
June 4, 2019

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access to the medicines that work to meet their individual needs?

To discuss this important issue, we sat down with Merck Chief Patient Officer Dr. Julie Gerberding to discuss how we can better understand the voices of patients, meeting the challenge of antimicrobial resistance (AMR), and Merck’s commitment to scientific excellence on behalf of patients.

Listen to the full podcast here: